Date published: 2026-4-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

BACE2 Inhibitors

Beta-secretase 2 (BACE2) is a protease enzyme primarily expressed in the brain, pancreas, and heart tissues, belonging to the aspartic protease family. Despite its structural similarity to BACE1, BACE2 exhibits distinct substrate specificity and tissue distribution. While BACE1 is primarily associated with the cleavage of amyloid precursor protein (APP) to generate amyloid-beta peptides implicated in Alzheimer's disease, the exact physiological role of BACE2 remains less understood. However, research suggests its involvement in regulating synaptic function, pancreatic beta-cell function, and myelination in the central nervous system, among other cellular processes. BACE2 has been implicated in the processing of neuregulin-1, a critical factor in neuronal development, and in the regulation of insulin secretion from pancreatic beta-cells. Moreover, BACE2 may play a role in modulating glucose metabolism and lipid homeostasis, thus indicating its potential significance beyond the central nervous system.The inhibition of BACE2 activity is a topic of interest in understanding its role in physiological and pathological processes, although the development of specific inhibitors has proven challenging due to its structural similarity to BACE1. However, various strategies have been proposed to inhibit BACE2 function. These include the design of small molecule inhibitors targeting the active site of the enzyme to block its catalytic activity. Additionally, modulation of BACE2 expression levels through gene silencing techniques, such as RNA interference, or through the regulation of its transcriptional activity may offer alternative approaches to inhibit its function. Furthermore, exploring the physiological mechanisms that regulate BACE2 activity, such as post-translational modifications or protein-protein interactions, could provide insights into novel strategies for inhibiting its activity. Overall, elucidating the mechanisms of BACE2 inhibition and its physiological functions holds promise for understanding its role in health and disease.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

β-Secretase Inhibitor IV

797035-11-1sc-222304
1 mg
$378.00
1
(1)

β-Secretase Inhibitor IV is characterized by its selective interaction with the β-site amyloid precursor protein cleaving enzyme 2 (BACE2). Its unique structure enables precise binding to the active site, disrupting substrate recognition and catalysis. The compound exhibits distinct kinetic properties, with a rapid onset of inhibition that alters the enzyme's conformational dynamics. This modulation of BACE2 activity influences amyloidogenic pathways, showcasing its intricate role in biochemical processes.

CCG 203971

1443437-74-8sc-507360
10 mg
$89.00
(0)

CCG-203971 functions as an inhibitor of BACE2 by binding to its active site, effectively blocking the enzyme's catalytic function. This interaction prevents the proteolytic processing of BACE2 substrates, resulting in the inhibition of downstream signaling pathways regulated by BACE2 activity.